Recommendations for RehabilitationWhen you hear the word "rehabilitation," what comes to mind?If you have spondyloarthritis, ...
Dr. Fox Remains a Shareholder and Member of the Board of Directors; Board Members Dr. David McFarland & Dr. Lorraine ...
Physical therapy isn't only for athletes. Anyone who needs help meeting movement goals and regaining independence can benefit ...
Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...
The Food and Drug Administration (FDA) recently approved a first-of-its-kind medication for treating Parkinson’s disease. Patients take JUVMO daily, a prescription medication that mimics the ...
On Monday, Sept. 28, the U.S. Food and Drug Administration approved a new treatment that targets dopamine pathways critical ...
Juvmo (tavapadon) offers a novel, selective D1/D5 dopamine receptor partial agonist mechanism for early monotherapy and adjunctive treatment in Parkinson disease.
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved JUVMO™ (tavapadon) tablets as the first and only selective D1/D5 receptor agonist for the treatment of ...
FDA gives go-ahead to D1/D5 dopamine agonist tavapadon ...
The FDA has approved tavapadon (AbbVie), a once-daily oral selective dopamine D1/D5 receptor partial agonist, for adults with ...
The ​US Food and ‌Drug Administration has approved AbbVie's drug ​for Parkinson's disease ​in adults, the health ⁠regulator's ...
When Celia was looking for a physical therapist who made home visits, she posted on the Teaneck shuls email list that she ...